Vered Yayon

Vered Yayon is a seasoned Director of Clinical Operations with over 15 years of experience in clinical trial operations and project management. Yayon has managed global clinical trials, particularly phase 3 studies in Europe, Canada, and the USA, contributing to the approval of the Hep-B vaccine across multiple regions. Currently overseeing operations at Nucleix Ltd., Yayon previously held senior roles at SciVac Limited and Synarc, focusing on vendor management, contract negotiations, and regulatory submissions. Yayon holds an M.B.A. from Ben-Gurion University of the Negev and a B.Sc. in Biochemistry and Food Sciences from The Hebrew University of Jerusalem.